Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cost-effectiveness of tenecteplase versus alteplase for acute ischemic stroke
C. Nguyen, Maarten M.H. Lahr, Durk-Jouke van der Zee, et al.
European Stroke Journal (2023) Vol. 8, Iss. 3, pp. 638-646
Open Access | Times Cited: 13

Showing 13 citing articles:

Tenecteplase vs Alteplase in Acute Ischemic Stroke Within 4.5 Hours
Lina Palaiodimou, Aristeidis H. Katsanos, Guillaume Turc, et al.
Neurology (2024) Vol. 103, Iss. 9
Closed Access | Times Cited: 20
Comparing Tenecteplase and Alteplase for Acute Ischemic Stroke
Chenchen Tu, Haiguang Mao, Jennifer L. Wessol
Journal of Neuroscience Nursing (2025)
Closed Access
Navigating the Shift: Comparing Safety and Cost of Tenecteplase versus Alteplase in Acute Ischemic Stroke
Cecilia Cassano, Daryl S. Schiller, Magda Fulman
The Neurohospitalist (2025)
Open Access
Tenecteplase for ischemic stroke at 4.5 to 24 hours without thrombectomy: a cost-utility analysis from the perspective of Chinese healthcare system
Maolin Chen, Ying Yu, Bo Yu, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
Drive-the-doctor paradigm in acute ischaemic stroke for improving regional stroke care networks: a cost-effectiveness analysis
C. Nguyen, Maarten Uyttenboogaart, Willemijn J Maas, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e091413-e091413
Open Access
Tenecteplase versus alteplase in patients with acute ischemic stroke: An updated meta-analysis of randomized controlled trials
Maheen Sheraz, N. Asif, Ariba Khan, et al.
Journal of Stroke and Cerebrovascular Diseases (2025), pp. 108300-108300
Open Access
Tenecteplase is here: navigating the shift of a stroke thrombolytic in the United States prior to FDA approval: a mini-review on rationale, barriers, and pathways
Julian M Burwell, Jason R Howay, Lisa Wasko, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
Bibliometric analysis of the usage of tenecteplase for stroke
Garv Bhasin, Latha Ganti
International Journal of Emergency Medicine (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Endovascular Thrombectomy Alone for Large Vessel Occlusion: A Cost-Effectiveness Evaluation Based on Meta-Analyses
C. Nguyen, Maarten M.H. Lahr, Durk-Jouke van der Zee, et al.
Stroke (2024) Vol. 55, Iss. 10, pp. 2482-2491
Closed Access
Acute ischemic stroke: Diagnosis and endovascular management
Janhavi Modak
Elsevier eBooks (2024), pp. 453-475
Closed Access
The evolution of tenecteplase as a bridging agent for acute ischemic stroke
Senta Frol, Gustavo M Cortez, Janja Pretnar Oblak, et al.
Journal of NeuroInterventional Surgery (2024), pp. jnis-022585
Closed Access
WITHDRAWN: Advances in Neurovascular Research: Scientific Highlights from the 15th World Stroke Congress
Joseph R. Geraghty, Fernando D. Testai
Journal of Stroke and Cerebrovascular Diseases (2024), pp. 107614-107614
Open Access
Advances in neurovascular research: Scientific highlights from the 15th world stroke congress
Joseph R. Geraghty, Fernando D. Testai
Journal of Stroke and Cerebrovascular Diseases (2024) Vol. 33, Iss. 5, pp. 107617-107617
Closed Access
Page 1

Scroll to top